Antonio Gallardo-Pizarro (@agallardop_) profile picture
Barcelona, España
Joined April 2024
Photo by Antonio Gallardo-Pizarro (@agallardop_)
Antonio Gallardo-Pizarro retweeted
In 1992 Peter Ratcliffe received this rejection from Nature. Almost 30 years later he won the Nobel Prize for the same discovery. Don't lose faith in the things you believe in.
124
1,840
170
7,404
432,114
Antonio Gallardo-Pizarro retweeted
Emotivo acto de conmemoración del 50 aniversario del Programa de #TPH del @hematoclinicbcn, bajo la actual dirección de la presidenta de @GETH_info. Una huella indeleble en pacientes, profesionales y el resto del ecosistema #TerCel de nuestro país. ¡Enhorabuena!
9
3
31
1,658
Antonio Gallardo-Pizarro retweeted
Oral poster; excellent work & presentation! Neutropenic patients with fever needs a personalized antibiotic approach based on machine learning and prior colonization #ProudOfMyTeam #ESCMIDGlobal2026 ⁦@hospitalclinic⁩ @escmid
1
1
16
784
Antonio Gallardo-Pizarro retweeted
📢Recordamos, V Reunión científica anual de GESITRA-IC @GesitraIC, @SEIMC_ 📅 5-6 de marzo 📍Madrid 📚📝Programa/inscripción 👇 seimc.org/grupos-de-estudio/…
5
11
561
Antonio Gallardo-Pizarro retweeted
The AMR Action Subcommittee and Study Group for Artificial intelligence and Digitalisation (ESGAID) recently published a perspective on the implications of using AI in the fight against #AMR. Check it out: ow.ly/Bbwm50YeZTF
1
10
11
1,127
Febrile neutropenia still drives heavy carbapenem use due to MDR Gram-negatives. In a cohort of 553 FN episodes, an ML risk model + prior colonisation data could cut meropenem use by ~30% and IEAT from 23% to 9%, supporting personalised EAT. journals.sagepub.com/doi/ful…
2
2
165
Based on expert opinion, national guidelines suggest obtaining 2 sets of blood cultures at the onset of FN and repeating cultures on FN days 2-3. 🆕⚡Retrospective cohort study of patients with hem/onc diagnoses & an FN episode >3d Detection of new BSI after FN day 3 was uncommon, demonstrating low diagnostic yield of repeat blood cultures after FN day 3. In a cohort of >500 patients with persistent FN, new BSI after FN day 3 was identified in 4% of patients and 2% of days with cultures collected. FN onset in the peri-HCT period (day -7 to +30) was associated with 80% lower odds of new BSI after FN day 3. Among new organisms in blood cultures after FN day 3, 26% were contaminants with over half leading to excess vancomycin use, highlighting the importance of diagnostic stewardship in this population. @BradSpellberg @DrToddLee ICYMI #IDXposts academic.oup.com/cid/article…
1
19
32
3,883
Antonio Gallardo-Pizarro retweeted
💥#ProudOfMyTeam 🎯New accepted paper! Impact of Novel β-Lactams on Gut Decolonisation in Haematological Patients with Multidrug-Resistant Gram-Negative Infections @sehh_es @SEIMC_ @ESCMID @EHA_Hematology @TheEBMT @hospitalclinic @idibaps sciencedirect.com/science/ar…
1
7
21
1,874
Tratamiento ambulatorio en pacientes con endocarditis infecciosa: análisis de las estrategias actuales. Marta Maristany @hospitalclinic en #SEICAV25 @IETeamClinicBCN #endocarditis
4
6
298
Antonio Gallardo-Pizarro retweeted
Gene therapy has long held promise for the treatment of Parkinson’s disease. In @TheLancetNeuro, authors explore clinical trials and technical advances in gene therapy for Parkinson's disease: hubs.li/Q03zZPW-0
3
52
3
142
12,447
⚠️ Brote de gripe H5N1 en granja de pavos en Badajoz.
34
1
39
5,845
Antonio Gallardo-Pizarro retweeted
A brilliant UCLA Hematologist, Dr. Gary Schiller, said something to me when I was a medical student that I didn't understand at the time, but in retrospect, turns out to have had a profound, long-lasting impact on me. Specifically, on how I view the concept of "expertise".
6
35
6
172
20,733
Antonio Gallardo-Pizarro retweeted
#JornadaHematoAvanza25 👉 El trasplante de médula ósea es la #terapia celular más antigua que existe, y con ella se han curado miles de personas. Para ello, es fundamental la #donacion. 📹Te lo explica en este video Montserrat Rovira, del @hospitalclinic y si quieres saber➕, no te pierdas su ponencia completa en nuestro canal de #HemoTube 👉Más allá del cáncer sanguíneo youtube.com/watch?v=fMFaXQmp… #HematoAvanza #HematoEnRed #THP #donamedula
7
14
902
Words matter. It’s time to retire the term oral “step-down.” It implies inferiority of the oral route—and doesn’t align with stewardship principles. Terms like IV to oral switch or oral transition better promote optimal antimicrobial stewardship. What terms do you use—and why?
6
23
1
65
7,962
Antonio Gallardo-Pizarro retweeted
🏥 El #CLÍNIC-@idibaps ha alcanzado un hito histórico con el tratamiento de más de 5️⃣0️⃣0️⃣ pacientes con terapias CAR-T propias. 🧬 Es el único hospital de Europa que ha desarrollado íntegramente dos terapias CAR-T académicas que están aprobadas por una agencia reguladora (AEMPS). 🔬 En la actualidad se están desarrollando nuevos CAR-T para tratar a pacientes con diferentes tipos de tumores sólidos o enfermedades hematológicas. La investigación se centra también en mejorar la funcionalidad de los CAR-T una vez llegan al tumor. 👉 f.mtr.cool/tvxpmtbipi
1
9
3
15
2,765
Antonio Gallardo-Pizarro retweeted
Qué es el SITRAME? Nuevo síndrome autoinflamatorio descrito en adultos. Atentos a las características: semejan celulitis recurrentes sobre todo en tronco con fiebre #SCAEDV #Dermatologia
1
38
111
11,009
Ya no se trata solo de elegir el antibiótico. En neutropenia febril, el cambio es de estrategia. IA y decisiones que importan. Nos vemos en Cartagena! 🦾 @Area2Cartagena
XXIV Jornadas sobre Actualización en Enfermedades Infecciosas: IA y E. infecciosas 📅26 y 27 de marzo de 2025 📍Murcia 📚📝Ampliar detalles (programa, inscripción) consultando el enlace👇 seimc.org/formacion-continua…
1
830